All-Wales Medicines Strategy Group

Restrictions on prescribing OTC treatments rejected in Wales

Proposals to restrict the prescribing of medicines and other treatments that are available over the counter will not go ahead in Wales.…

Three-year PrEP pilot begins in Wales

A trial has begun in Wales to assess the use of the antiretroviral combination treatment emtricitabine/tenofovir disoproxil (marketed as Truvada) for pre-exposure prophylaxis (PrEP) against HIV infection.…

Treatment fund launched in Wales for newly approved drugs

An £80m new treatment fund to pay for high-cost drugs approved for use on the NHS in Wales has been launched.…

Welsh audit body recommends managing medicines plan

The government, the NHS and health bodies should revise the indicators used to compare how different prescribers and organisations use medicines, says a report by the Welsh Audit Office.…

Gething confirms £80m fund for high-cost medicines in Wales

A central fund worth £80m that will pay for the immediate use of new, high-cost medicines that are approved for use in Wales has been announced by Vaughan Gething, cabinet secretary for health for the Welsh government.…

Welsh Labour pledge to create £80m central fund for high cost drugs

Welsh Labour has pledged to create an £80m central fund to pay for high cost medicines if they retain control of the National Assembly for Wales following the election on 5 May 2016.…